Trial Profile
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients with Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Jul 2020
Price :
$35
*
At a glance
- Drugs Decoglurant (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms ARTDeCo
- Sponsors Roche
- 14 Jul 2020 Results published in the Journal of Clinical Psychiatry
- 19 Aug 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 23 Jan 2014 Planned End Date changed from 1 May 2014 to 1 Jun 2014 according to ClinicalTrials.gov.